Mon, 03/14/2016
GW Pharmaceuticals has announced positive results from the first of two Phase 3 studies of Epidiolex® (cannabidiol or CBD) in the treatment of Dravet syndrome. Median seizure reduction was 39% with Epidiolex versus only 13% with placebo, a...
Wed, 03/09/2016
We thank award-winning actor Harrison Ford for talking, again, about epilepsy. Ford spoke in honor of Dr. Orrin Devinsky at the New York University (NYU) Langone Medical's Center's annual Finding A Cure for Epilepsy and...
Tue, 03/08/2016
(Austin, TX) – Today the House Human Services Committee held a hearing to discuss prescription drug costs in Texas’ Medicaid program. One of the proposals would allow managed care companies to create their own formularies and could jeopardize access...
Tue, 03/08/2016
(Landover, MD -3/8/2016) - The Epilepsy Foundation, the nation’s leader in epilepsy and seizures information and engagement, announced the launch of their new web tool “My Seizure Diary” (diary.epilepsy.com). With over 40,000 users and 60+ new...
Fri, 03/04/2016
(Landover, MD) - The Epilepsy Foundation, the nation’s leader in epilepsy and seizure information and engagement, hosted hundreds of investors, emerging biotech and medical technology companies, major pharmaceutical and device companies, and...

Pages